Discover Dexcom Continuous Glucose Monitoring (CGM) Technology

See how Dexcom products can help optimize your patients' glucose control and support a greater quality of life.

A leader in diabetes care

Dexcom is dedicated to developing innovative glucose monitoring technology and products to help patients and healthcare providers better manage diabetes.

As the world's first real-time, integrated CGM (iCGM), the Dexcom G6 Continuous Glucose Monitoring (CGM) System offers a range of features and benefits that help make that possible.

1st mobile CGM system

1st CGM system indicated for non-adjunctive use (insulin dosing without fingersticks*)

1st therapeutic CGM system covered by Medicare

1st integrated CGM (iCGM)--an FDA designation based on rigorous performance standards

*If your glucose alerts and readings from Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Redefining the CGM landscape

Dexcom wrote the next chapter in CGM technology with the development of Dexcom G6: a zero-fingersticks, integrated CGM system that's the preferred choice of endocrinologists.*^,†

Supports improved diabetes management

Smart device compatibility

Compatible smart devices are sold separately: dexcom.com/compatibility

Zero fingersticks* and scanning required

*If your glucose alerts and readings from the Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Accuracy during critical times³

Supports improved glycemic outcomes (multiple measures)^4-7

Real-time glucose data sharing

Do not make diabetes treatment decisions based upon Dexcom Share and Dexcom Follow app readings. Always confirm with your compatible smart device or Dexcom receiver.

Customizable high and low alerts

Get the Most Out of Patient Visits at the Clinic

If a patient consents to share their glucose data, healthcare providers may be able to access the patient's CGM reports that show their glucose patterns, trends, and statistics. Learn more about Dexcom Clarity and how you can incorporate the software into your practice, for optimized patient conversations during your in-person or telehealth appointments.^||,¶

Widespread Coverage

Dexcom CGM is covered as a medical benefit for 98% of commercial insurance plan holders who have type 1 diabetes, and a growing number of plans cover CGM for insulin-using type 2 diabetes patients. For people whose plans cover CGM as a pharmacy benefit, their Dexcom CGM prescription may be processed at local retail pharmacies. Dexcom CGM is covered by Medicare - the first mobile-enabled, therapeutic CGM to achieve Medicare coverage, and by Medicaid.

Why CGM

What is CGM?

Learn how continuous glucose monitoring (CGM) is a powerful tool to help improve diabetes management.

Proven Outcomes

Review evidence demonstrating the impact CGM use can have on glycemic control.

Patient Benefits

Whether type 1 or type 2, injections or pump, your patients may benefit.

*% of CGM readings within ±15 mg/dL of YSI lab reference values ≤ 100mg/dL or ±15% of YSI values > 100mg/dL.

^†Analogous to %15/15 (see previous footnote).

^‡MARD is a statistical measure of accuracy; the lower the number, the better.

^§Unless noted otherwise, adult and pediatric data are combined.

^IIDo not use Dexcom Clarity for treatment decisions such as dosing insulin. The user should follow instructions on the continuous glucose monitoring system.

^¶Register for Dexcom Clarity at clarity.dexcom.com/professional/registration

¹ Shah VN, et al. Diabetes Technol Ther. 2018.

² Wadwa RP, et al. Diabetes Technol Ther. 2018.

³ Dexcom G6 CGM System User Guide, 2018.

⁴ Beck RW, et al. JAMA. 2017;317(4):371-378.

⁵ Reddy M, et al. Diabet Med. 2017.

⁶ Heinemann L, et al. Lancet. 2018.

⁷ Welsh JB et al. Diabetes Technol Ther 2019;21(3):128-32.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request a G7 Sample

Request Stelo Education Materials

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider’s medical license (no MD, Jr., Sr.)

Please use the Provider’s NPI

Please provide Facility/Office address Only- We will not ship to home address

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.